ViewTube

The National Vaccine Injury Compensation Program helps patients by providing a fair and efficient way to seek compensation in ...

Takeda is partnering with local organizations, like Community Servings, to build healthier, more resilient communities. Community ...

For years, the 340B program has operated largely outside of public view with little transparency or oversight. Now, national ...

America's biopharmaceutical leadership is the result of 250 years of ingenuity paired with deliberate policy choices that rewarded ...

A new TEConomy report highlights how the biopharmaceutical industry is investing in workforce training, apprenticeships and ...

340B markups are a goldmine for big, nonprofit hospital systems. They can mark medicines up to 1000% or more -- and with no ...

Thanks to strong American leadership, patients here get new medicines 3 years faster than patients in other countries. But that ...

A brain tumor diagnosis changed everything for Melissa. Thanks to medical innovation and fast access, she received life-saving ...

Kyowa Kirin is investing in U.S. manufacturing and advancing next-generation biopharmaceutical innovation from antibodies to ...

Biopharma companies are working to bring next-generation cancer treatments to American patients When America leads in ...